Sinopharm Group
(OTC) SHTDY
Sinopharm Group Financials at a Glance
Market Cap
$3.57B
Revenue (TTM)
$1.15T
Net Income (TTM)
$14.13B
EPS (TTM)
$1.60
P/E Ratio
8.33
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Price
$13.29
Volume
20,065
Open
$13.52
Price
$13.29
Volume
20,065
Open
$13.52
Previous Close
$13.29
Daily Range
$13.16 - $13.86
52-Week Range
$10.84 - $14.87
Dividend
$0.47
Beta (Volatility)
0.35 (Low)
Price
$13.29
Volume
20,065
Open
$13.52
Previous Close
$13.29
Daily Range
$13.16 - $13.86
52-Week Range
$10.84 - $14.87
SHTDY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sinopharm Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
94,910
Website
ir.sinopharmgroup.com.cnHeadquarters
Shanghai, 200023, CN
SHTDY Financials
Key Financial Metrics (TTM)
Gross Margin
7%
Operating Margin
3%
Net Income Margin
1%
Return on Equity
9%
Return on Capital
11%
Return on Assets
2%
Earnings Yield
12.00%
Dividend Yield
0.04%
Payout Ratio
68.56%
Stock Overview
Market Cap
$3.57B
Shares Outstanding
268.36M
Volume
20.07K
Short Interest
0.00%
Avg. Volume
56.94K
Financials (TTM)
Gross Profit
$40.09B
Operating Income
$16.21B
EBITDA
$20.38B
Operating Cash Flow
$11.55B
Capital Expenditure
$1.97B
Free Cash Flow
$9.58B
Cash & ST Invst.
$61.60B
Total Debt
$108.65B
Sinopharm Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$283.78B
-4.0%
Gross Profit
$20.70B
-18.0%
Gross Margin
7.29%
N/A
Market Cap
$3.57B
N/A
Market Cap/Employee
$32.96K
N/A
Employees
108,217
N/A
Net Income
$3.62B
-26.8%
EBITDA
$11.06B
-18.0%
Quarterly Fundamentals
Net Cash
$47.05B
-371.8%
Accounts Receivable
$206.78B
+11.3%
Inventory
$63.38B
+5.6%
Long Term Debt
$6.14B
-64.4%
Short Term Debt
$102.51B
+81.3%
Return on Assets
1.81%
N/A
Return on Invested Capital
11.28%
N/A
Free Cash Flow
$34.78B
+21.0%
Operating Cash Flow
$34.11B
+21.3%